11:29 AM EDT, 04/04/2024 (MT Newswires) -- Charles River Laboratories International ( CRL ) will help therapeutics company Ship of Theseus produce good manufacturing practice-grade plasmid DNA to serve as the active drug substance for its lead candidate, the companies said Thursday.

The collaboration will support therapeutic development for various target indications, including diabetic and chronic wounds, women's health and infertility, and epithelial cancers, the companies said.

Price: 256.03, Change: -3.28, Percent Change: -1.26